World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2016
Main ID:  NCT02601131
Date of registration: 28/10/2015
Prospective Registration: Yes
Primary sponsor: Region Skane
Public title: Post-transfusion Platelet Count
Scientific title: Post-transfusion Platelet Count
Date of first enrolment: February 2016
Target sample size: 80
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02601131
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Sweden
Contacts
Name:     Thomas Kander, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Region Skåne
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients admitted to the Clinic of Hematology Diseases, Skåne University Hospital,
Lund, Sweden belonging to either of the groups described in paragraph 8 above and are
prescribed platelet transfusion.

Exclusion Criteria:

- Patients with aplastic anemia or treatment with antithymocyte globulin (ATG)



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Leukemia
Multiple Sclerosis
Intervention(s)
Biological: Platelet transfusion
Primary Outcome(s)
Change in platelet count after platelet transfusion [Time Frame: 4 days after platelet transfusion]
Secondary Outcome(s)
Analysis of platelets in platelet transfusions given to patients included in the study [Time Frame: 4 days after platelet transfusion]
Change in concentrations of complement factors in plasma after platelet transfusion [Time Frame: 4 days after platelet transfusion]
Change in concentrations of complement factors in platelet rich plasma after platelet transfusion [Time Frame: 4 days after platelet transfusion]
Change in concentrations of endothelial markers in plasma after platelet transfusion [Time Frame: 4 days after platelet transfusion]
Secondary ID(s)
Post-transf-PLC
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history